Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Clin Oncol. Jun 24, 2025; 16(6): 108113
Published online Jun 24, 2025. doi: 10.5306/wjco.v16.i6.108113
Figure 1
Figure 1 Vitamin D deficiency prevalence rates by prostate cancer stage, with the highest prevalence observed in metastatic castration-resistant prostate cancer. mCSPC: Metastatic castration-sensitive prostate cancer; mCRPC: Metastatic castration-resistant prostate cancer.